Unlike THC (tetrahydrocannabinol), another compound found in marijuana and some hemp strains, CBD is not psychoactive and therefore does not give users a “high.” Instead, scientists have focused on CBD for its plethora of health-promoting effects, which may be useful for a variety of conditions as well as general health optimization.
Why CBD Helps With Alcohol Withdrawal
First, we will give a brief overview of CBD. We will clarify the difference between CBD oil extracted from hemp and the use of marijuana for alcohol withdrawal. We will then discuss research that is relevant for the use of CBD for alcohol withdrawal, as well as my favorite CBD brand and further considerations for people who want to use CBD for alcoholism.
CBD And Alcohol: What Is CBD?
Since marijuana strains contain varying proportions of these compounds, it can be difficult to determine how much THC or CBD one is consuming when consuming this plant. Generally, indica-dominant strains contain higher levels of CBD, while sativa-dominant strains contain a relatively higher proportion of THC.
New treatment strategies for treating symptoms of alcohol dependence are urgently needed. Although alcohol related disorders are a leading cause of preventable death in Australia, their treatment is generally not evidence-based. Contemporary treatment for managing alcohol withdrawal in Australia involves administration of benzodiazepines that, while often effective for managing withdrawal symptoms, have concerns regarding their use including: a major abuse liability potential in this population; their sedating effects and potential for adverse events (e.g. falls, overdose, cognitive impairment) if used in combination with other sedatives; and an increased risk of relapse due to symptoms of alcohol dependence that return after cessation of treatment (e.g. increased sleep problems and anxiety). However, no other safe and effective alternatives to benzodiazepines in treating alcohol withdrawal have yet been demonstrated.
This is a double-blind, randomised controlled design. The trial will recruit 52 participants undergoing alcohol withdrawal, using a 1:1 random allocation into one of two treatment groups as follows: (1) CBD (Day 1: 1200 mg/day; Day 2-4: 800 mg/day; Day 5: placebo washout; n = 26), or (2) matched placebo (n = 26). All participants will be administered a symptom triggered diazepam medication regimen, as per conventional best-practice management of alcohol withdrawal.